Biohaven Brings Clifford Bechtold Aboard as Chief Operating Officer

Xconomy New York — 

Biohaven (NYSE: BHVN) has appointed Clifford Bechtold to serve as chief operating officer of the New Haven, CT, company. Bechtold most recently worked at Bristol-Myers Squibb (NYSE: BMY) as development team leader for genetically defined diseases. His work there encompassed programs in neuromuscular and neurodegenerative diseases. Biohaven is developing treatments for neurological diseases.